Teva Pharm announces settlement of generic Avandia, Avandamet, and Avandaryl litigation with GlaxoSmithKline

Thu Sep 27, 2007 5:05pm EDT

Co announced that the District Court case has been settled on terms that are confidential allowing TEVA by license to enter the U.S. market with its generic versions of Avandia (Rosiglitazone Maleate), Avandamet (Rosiglitazone Maleate/Metformin HCl) and Avandaryl (Rosiglitazone Maleate/Glimepiride) oral tablets late in Q1, 2012.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.